CEO Spotlight: Michael Forbes – Leading the Way in Future Health and Longevity 

Covid-19 Isn’t Over: Hospitalizations Ups, Vaccines Down and Cannabis Reducing Symptoms? 

The Hidden Epidemic in Your Pantry: Time for a Food Safety Revolution

Are you ready for AI in healthcare?

Unleashing the Potential of Psychedelic Lifestyle Products: Exploring Investment Opportunities

Biohacking: Unlocking the Future of Optimal Health

Emerging Biotech Breakthroughs: Promising Stocks in Medical Innovation

Unveiling the Upcoming Trends in Big Pharma Stocks for 2023: Key Players and Emerging Opportunities

Recent News

Google Research Expands AI Diabetic Retinopathy Screening

What You Should Know:  – Google Research is taking a significant step towards reducing preventable blindness by expanding access to

Pip Care Raises $5M for AI-Powered Surgical Journey Platform

What You Should Know:  – Pip Care, a company revolutionizing the surgical experience for patients and care teams, has successfully

TARGET CORRIDOR FOR ADJUSTED EBIT MARGIN CONFIRMED WITH ADJUSTMENT TO 2024 SALES GUIDANCE – Biotech Investments

STRATEC SE / Key word(s): Preliminary Results/Change in Forecast STRATEC POSTS PRELIMINARY RESULTS FOR FIRST NINE MONTHS OF 2024: TARGET

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Subscribe

* indicates required

Latest Pharma News

Bavarian Nordic’s mpox vaccine was safe and spurred promising immune response in children

Bavar­i­an Nordic’s mpox vac­cine Jyn­neos gen­er­at­ed a sim­i­lar im­mune re­sponse in ado­les­cents as it did in adults, of­fer­ing en­cour­ag­ing re­sults

Compounding association to ask for clarity around tirzepatide’s shortage status

The Al­liance for Phar­ma­cy Com­pound­ing (APC) wants clar­i­ty around the FDA’s de­ci­sion to re­con­sid­er tirzepatide’s re­moval from its na­tion­al short­age

Latest Cannabis News

Geography Matters for the Cannabis Industry

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015.

Illinois Cannabis Sales Slump In September

Illinois released sales figures for adult-use cannabis in September today. They were down 7.4% sequentially to $136.5 million. On a per-day basis, sales

Latest biotech News

Google Research Expands AI Diabetic Retinopathy Screening

What You Should Know:  – Google Research is taking a significant step towards reducing preventable blindness by expanding access to

Pip Care Raises $5M for AI-Powered Surgical Journey Platform

What You Should Know:  – Pip Care, a company revolutionizing the surgical experience for patients and care teams, has successfully

Latest Life Science News

New study reveals two-thirds of diabetic men suffer from erectile dysfunction

Erectile dysfunction (ED) affects up to 66% of diabetic men globally, with risk factors like age, long-term diabetes, and obesity

Study identifies genetic associations with youth psychopathology

When trying to understand how genetic influences factor into youth behavior, researchers at Washington University in St. Louis have taken

Latest psychedelics News

Dr. Alan K. Davis | Director, Center for Psychedelic Drug Research and Education | Psychedelic Finance

Dr. Alan K. Davis is a Clinical Psychologist and the Director of the Center for Psychedelic Drug Research and Education

MindBio Announces Proposed Issuance of Listed Securities | Psychedelic Invest

Vancouver, British Columbia –TheNewswire –October 16, 2024–MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6),(the “Company” or “MindBio”),a leading biopharmaceutical company in psychiatric medicine

videos